Obesity

Showing NaN - NaN of 53

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Obesity Trial in United States (S-2367 (velneperit))

Completed
  • Obesity
  • S-2367 (velneperit)
  • Birmingham, Alabama
  • +72 more
Apr 26, 2018

Metabolism and Nutrition Disorder, Obesity Trial in Worldwide (liraglutide, )

Completed
  • Metabolism and Nutrition Disorder
  • Obesity
  • Birmingham, Alabama
  • +225 more
Dec 20, 2017

Metabolism and Nutrition Disorder, Obesity Trial in Worldwide (liraglutide, )

Completed
  • Metabolism and Nutrition Disorder
  • Obesity
  • Vestavia Hills, Alabama
  • +160 more
Dec 6, 2017

Metabolism and Nutrition Disorder, Obesity Trial in Canada, United States (liraglutide, )

Completed
  • Metabolism and Nutrition Disorder
  • Obesity
  • Goodyear, Arizona
  • +36 more
Sep 29, 2017

Obesity, Overweight Trial in United States (NB32, PBO, Weight Management Program)

Terminated
  • Obesity
  • Overweight
  • Birmingham, Alabama
  • +223 more
Feb 24, 2017

Obesity, Cardiovascular Diseases Trial in United States (Naltrexone HCl/Bupropion HCl ER, Placebo)

Terminated
  • Obesity
  • Cardiovascular Diseases
  • Naltrexone HCl/Bupropion HCl ER
  • Placebo
  • Alexander City, Alabama
  • +138 more
Feb 21, 2017

Obesity Trial in Cincinnati (Behavioral Family Intervention, Motivational Interviewing)

Completed
  • Obesity
  • Behavioral Family Intervention
  • Motivational Interviewing
  • Cincinnati, Ohio
    Cincinnati Children's Hospital Medical Center
Dec 27, 2016

Obesity Trial in Cincinnati (Cooking)

Completed
  • Obesity
  • Cooking
  • Cincinnati, Ohio
    Cincinnati Children's Hospital Medical Center
Jul 13, 2015

Obesity Trial in United States (pramlintide acetate, )

Completed
  • Obesity
  • pramlintide acetate
  • placebo
  • Chula Vista, California
  • +20 more
Jun 10, 2015

Obesity Trial in United States (Betahistine, Dietary counseling)

Completed
  • Obesity
  • Birmingham, Alabama
  • +18 more
Apr 20, 2015

Obesity Trial in United States (Placebo, Pramlintide and Metreleptin)

Completed
  • Obesity
  • Placebo
  • Pramlintide and Metreleptin
  • Birmingham, Alabama
  • +32 more
Mar 26, 2015

Overweight, Obesity Trial in United States (pramlintide acetate, metreleptin, -P)

Completed
  • Overweight
  • Obesity
  • pramlintide acetate
  • +3 more
  • Birmingham, Alabama
  • +35 more
Mar 26, 2015

Overweight, Obesity Trial in United States (pramlintide acetate 360 mcg, metreleptin, -pramlintide 600 uL)

Completed
  • Overweight
  • Obesity
  • pramlintide acetate 360 mcg
  • +4 more
  • Deland, Florida
  • +11 more
Mar 26, 2015

Obesity Trial in United States (pramlintide acetate)

Completed
  • Obesity
  • pramlintide acetate
  • Chula Vista, California
  • +20 more
Apr 9, 2015

Obesity, Overweight Trial in United States (AC2307, )

Completed
  • Obesity
  • Overweight
  • Birmingham, Alabama
  • +17 more
Jan 16, 2015

Obesity Trial in Cincinnati (Blueberry Smoothie, Sham Smoothie)

Completed
  • Obesity
  • Blueberry Smoothie
  • Sham Smoothie
  • Cincinnati, Ohio
    Cincinnati Children's Hospital Medical Center
Dec 16, 2014

Obesity, Overweight Trial in United States (Naltrexone SR 32 mg/bupropion SR 360 mg/day, Placebo, Ancillary therapy)

Completed
  • Obesity
  • Overweight
  • Naltrexone SR 32 mg/bupropion SR 360 mg/day
  • +2 more
  • Phoenix, Arizona
  • +35 more
Nov 18, 2014

Obesity Trial in Cincinnati (Clinic + Home Behavioral Intervention, Pediatrician Counseling, Clinic Only Behavioral

Completed
  • Obesity
  • Clinic + Home Behavioral Intervention
  • +2 more
  • Cincinnati, Ohio
    Cincinnati Children's Hospital Medical Center
Oct 20, 2014

Development of PK/PD Model for Individualized Propofol Dosing

Completed
  • Obesity
  • Elective Surgery
    • Cincinnati, Ohio
      Cincinnati Children's Hospital Medical Center
    Jan 8, 2014

    Obesity, Insulin Resistance Trial in Worldwide (MICARDIS® (telmisartan))

    Completed
    • Obesity
    • Insulin Resistance
    • MICARDIS® (telmisartan)
    • Los Angeles, California
    • +16 more
    Oct 31, 2013

    CV Disease in Adolescents With Type 2 Diabetes

    Completed
    • Cardiovascular Diseases
    • +3 more
      • Cincinnati, Ohio
        Cincinnati Children's Hospital Medical Center
      Jul 31, 2012

      Metabolic Factors of Outcomes From Gastric Bypass Surgery

      Terminated
      • Obesity
        • Cincinnati, Ohio
          Veterans Affairs Medical Center
        Apr 19, 2012

        Evaluation of a Weight Management Program

        Completed
        • Obesity
        • Comprehensive weight management program
        • Fort Wayne, Indiana
        • +3 more
        Sep 21, 2011

        Obesity, Weight Loss Trial in Canada, United States (Rimonabant (SR141716))

        Completed
        • Obesity
        • Weight Loss
        • Rimonabant (SR141716)
        • Birmingham, Alabama
        • +50 more
        Apr 17, 2009

        Obesity, Dyslipidemia Trial in Worldwide (Rimonabant (SR141716))

        Completed
        • Obesity
        • Dyslipidemia
        • Rimonabant (SR141716)
        • Mesa, Arizona
        • +34 more
        Apr 17, 2009